Frigault, M. J., & Maus, M. V. (2020). State of the art in CAR T cell therapy for CD19(+) B cell malignancies. J Clin Invest.
Citação norma ChicagoFrigault, Matthew J., and Marcela V. Maus. "State of the Art in CAR T Cell Therapy for CD19(+) B Cell Malignancies." J Clin Invest 2020.
Citação norma MLAFrigault, Matthew J., and Marcela V. Maus. "State of the Art in CAR T Cell Therapy for CD19(+) B Cell Malignancies." J Clin Invest 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.